COMPANY PROFILE

Cerêve

Explore full profile

Working on Ebb insomnia therapy devices

United StatesFounded 2008Health Tech & Medtech

Valuation $100–250M Last recorded · 2017

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Cerêve

Cereve, Inc. is a pioneering company in the sleep health industry, dedicated to developing innovative solutions for insomnia sufferers. Founded by Dr. Eric Nofzinger, a renowned sleep physician, the company focuses on creating a clinically proven device that provides a safe and effective drug-free treatment for insomnia. The device is designed for nightly use without the side effects commonly associated with sleeping pills, making it a viable alternative for those seeking better sleep quality. Cereve serves individuals struggling with insomnia, a condition affecting nearly a third of the population, directly or indirectly impacting their daily lives. The company operates in the healthcare and wellness market, targeting consumers who are looking for non-pharmaceutical solutions to improve their sleep. The business model revolves around the development, manufacturing, and direct-to-consumer sales of its sleep device. Revenue is generated through the sale of the device, which is marketed as a long-term investment in better sleep health.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2008
Headquarters: United States
Open positions: None listed
Dealroom signal: 21.7/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Neurology, Hard Tech, DT and LS, science-based
Technology: Artificial Intelligence, Big Data, Deep Tech, Computer Vision
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Jan 2017	$38M	$152M	Undisclosed	—

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Cerêve website traffic

Latest recorded traffic for Cerêve is 510 monthly website visits, up 41.7% over the last three months.

Latest monthly visits510 3-month web change+41.7%

Monthly website visitsOct 2017–Feb 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MTMedyMatch TechnologyMedyMatch delivers real time decision support tools to improve clinical outcomes	Tel Aviv-Yafo, Israel	Operational	4	$2M	$8M
BSBioLum SciencesDeveloper of a biomarker detection platform for chronic inflammatory diseases	Dallas, United States	Operational
AIAdvantis Medical ImagingHealth Care, Medical Device, SaaS, Software Advanced Medical Imaging in the Cloud!	Eindhoven, Netherlands	Operational
STSurgical TheaterPatient-specific 3D imaging, adapted from flight simulation technology, for planning and rehearsing complex surgical procedures	Los Angeles, United States	Operational
UMUmooveFace and eye tracking, software only technology, for mobile devices. Powering applications in health, security, gaming and more	Jerusalem, Israel	Low Activity
SDSynaptic DelverBuilding the World’s First Cognitive Intelligence Infrastructure.	Singapore, Singapore	Operational
ONOmniscient NeurotechnologyEnterprise grade clinical and research solutions applicable to a variety of brain-related disorders	Sydney, Australia	Operational
BOBioMinds Healthcare Sp. z o.o.A new way for neurological rehabilitation - system for remote rehabilitation operating in augmented and virtual reality for sick and healthy persons	Lublin, Poland	Operational